Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Paratek Pharmaceuticals, Inc. Transaction History

Commonwealth Of Pennsylvania Public School Empls Retrmt Sys

$15.5 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$4.8 - $11.6 $731,284 - $1.77 Million	-152,351 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$9.05 - $10.95 $1.84 Million - $2.23 Million	-203,389 Reduced 57.17%	152,351 $1.48 Million
Q2 2018 Aug 03, 2018	SELL	$10.2 - $13.9 $5.84 Million - $7.96 Million	-572,408 Reduced 61.67%	355,740 $3.63 Million
Q1 2018 May 09, 2018	BUY	$12.65 - $18.85 $7.01 Million - $10.4 Million	554,248 Added 148.23%	928,148 $12.1 Million
Q4 2017 Feb 13, 2018	BUY	$17.45 - $25.6 $546,865 - $802,278	31,339 Added 9.15%	373,900 $6.69 Million
Q3 2017 Nov 09, 2017	BUY	$18.9 - $28.2 $6.47 Million - $9.66 Million	342,561	342,561 $8.6 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.

Account